Anthera Pharmaceuticals Announces 1-for-8 Reverse Split of Stock
July 12, 2013 at 17:02 PM EDT
Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH ) announced today that it has filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation to effect a 1-for-8 reverse stock split of its common stock, effective as of 5:00PM Eastern Time today. A Certificate of Amendment to effect
